Primary Human Cells
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Food and Drug Administration is forecasted to require primary human trophoblast cells to support research initiatives under the Perinatal Health Center of Excellence, with the opportunity posted on May 25, 2026. These cells are essential for advancing scientific understanding in perinatal health and will be used exclusively for federally funded research programs. The solicitation falls under the NAICS code 541990, indicating it pertains to other scientific and technical consulting services, and while no set-aside designation or contracting details are currently specified, the procurement is anticipated to involve specialized biological materials meeting strict quality and sourcing standards. Point of contact for program inquiries is the Nctr Acquisition Liaison at nctracquisitions@fda.hhs.gov, while the contracting officer position remains to be filled. Performance location and specific delivery requirements are not yet defined, and interested parties should monitor the official OSDBU portal for future updates and formal solicitations.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
